DOH-backed Future Health takes 15-country prevention and AI pitch to New York

Future Health, a Department of Health Abu Dhabi (DOH)-convened initiative, brought ministers, regulators and health leaders from 15 countries to New York during UNGA 81 to promote prediction, prevention and AI-led population health.

The highest-stakes readers are COOs, CFOs and CIOs. For clinics, the signal is that preventive screening, referral management and patient-risk data are moving closer to the operating model regulators want. For insurers, including Daman, Thiqa and Sukoon where policy terms apply, the question is whether earlier intervention can reduce claims cost without adding unfunded utilisation.

What Abu Dhabi took to New York

The Future Health announcement, dated 27 September 2026, said the dialogue was chaired by H.E. Ahmed Al Sayegh, UAE Minister of Health and Prevention. Participants included representatives from Angola, Brazil, Ethiopia, Finland, Guyana, Indonesia, Madagascar, Mali, Nigeria, Rwanda, Sweden, the UAE, the UK, Tanzania and the US.

The programme identified four requirements for preventive health systems: population data, financing incentives, delivery capacity and trust. That framing matters in the UAE because Dubai, Abu Dhabi and the northern emirates have different licensing and payer structures. Dubai Health Authority (DHA) regulates Dubai providers, DOH regulates Abu Dhabi and Al Ain, and the Ministry of Health and Prevention (MOHAP) regulates the northern emirates.

"Insight alone will not improve health." H.E. Dr Ahmed AlKhazraji, Executive Director of Healthy Living, DOH Abu Dhabi

Dr Ahmed AlKhazraji told the New York dialogue that Abu Dhabi is applying its Healthy Living Strategy through communities, workplaces and schools. Future Health also cited its white paper, The Future of Healthy Living: A $16.4 trillion Opportunity, which says 19 of 23 drivers shaping health sit outside formal healthcare.

Why clinics and insurers should care

For Dubai clinics, the practical question is whether prevention becomes a larger part of patient acquisition and payer contracting. A clinic that depends on episodic GP, diabetes, cardiology or obesity visits should track DHA circulars, insurer pre-authorisation rules and employer benefit design. If screening pathways become tied to reimbursement, clinics will need recall systems, consent workflows and measurable follow-up rates.

In Abu Dhabi, providers should watch DOH programmes around healthy living, life sciences and health data. The New York announcement named PureHealth, M42, the Institute for Healthier Living Abu Dhabi and Mubadala Bio as Future Health founding partners. Mediclinic Middle East was named strategic partner and Burjeel Holdings associate partner.

• COOs: map existing screening, referral and follow-up workflows against DHA, DOH or MOHAP licence requirements.
• CFOs: ask insurers which preventive checks are covered, excluded or subject to pre-approval in each network contract.
• CIOs: verify whether EHR, CRM and call-centre tools can segment patients by risk and document outreach consent.
• Medical directors: set clinical governance for AI tools before staff use them in triage, screening or patient messaging.

Typical UAE clinic prices vary by emirate, network and package. Operators should use their own tariff file, payer contract and regulator-approved service list rather than public package prices when modelling margin. For patients, the actionable check is simpler: confirm licence status, insurer network status and whether the test or consultation needs approval before booking.

The UAE operating implication

The New York event does not create a new UAE compliance deadline. Its importance is strategic. Abu Dhabi is positioning prevention, AI and life sciences as exportable health-system capabilities, while Dubai providers compete for insured outpatient volume and MOHAP-regulated clinics serve price-sensitive and geographically dispersed patients.

Clinics that want to act now should audit three items in the next 30 days: which patients are overdue for evidence-based screening, which outreach messages have documented consent, and which insurer contracts pay for follow-up after an abnormal result. That turns a policy discussion into a measurable operating plan.

Patients and operators comparing licensed providers should start with the UAE Open Healthcare Directory, which lists 12,390+ licensed healthcare providers across all seven emirates and anchors facility records to DHA, DOH and MOHAP registers.